The public cancer centre for southern Kyrgyzstan, in the city of Osh. It has a palliative care department, and the Ministry of Health's strategy for 2021 to 2025 planned to develop radiotherapy there.
The Ministry of Health's cancer strategy for 2021 to 2025 (order No. 1019 of 28 July 2021, posted on the ICCP portal) lists the Osh Interregional Oncology Centre, with 100 beds, second among the public cancer services, after the National Center of Oncology and Hematology in Bishkek. The strategy says radiotherapy should be developed at the Osh centre and that, until then, travel and lodging should be funded for patients who must go to Bishkek; it also plans a hospital cancer registry at the centre. OnCo did not find a source saying whether radiotherapy has since opened in Osh. The European Observatory's 2022 health system review describes a palliative care department of five beds at the centre, funded by the Mandatory Health Insurance Fund, and a 2018 paper dates the start of palliative care in Kyrgyzstan to a home care pilot at the Osh cancer centre in 2005. The IAEA's 2015 imPACT review team met the centre's director. OnCo read no website of the centre. The coordinates are an approximate Osh city point, not the building.
About six in ten of the liver cancers studied (348 of 572, counting the 17 people with both infections once) were attributed to hepatitis B or C, infections that can be prevented by vaccination or treated. The authors call for earlier testing and treatment. Liver cancer is the third commonest cause of cancer death in IARC's 2024 estimate for Kyrgyzstan.
Registered breast cancer is commonest around the capital, where diagnosis is most available, and rising in the south. A registry counts what is diagnosed and reported, so lower regional rates may partly reflect cancers that were not found.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/